Description
A PP2A inhibitor with anticancer activity; cytotoxic to BxPC-3 and PANC-1 cells (IC50s = 0.85 and 3.87 μM, respectively); inhibits radiation-induced Rad51 focus formation and homologous recombination repair in PANC-1 and MiaPaCa-2 cells; increases tumor microvessel density and VEGF secretion and decreases tumor volume in a PANC-1 mouse xenograft model at 2 mg/kg; enhances radiation-induced reductions in tumor volume in CNE1 and CNE2 radioresistant nasopharyngeal carcinoma mouse xenograft models at 1.5 mg/kg
Formal name: (1R,4S)-rel-3-[(4-methyl-1-piperazinyl)carbonyl]-7-oxabicyclo[2.2.1]heptane-2-carboxylic acid
Synonyms:
Molecular weight: 268.3
CAS: 1632032-53-1
Purity: ≥98%
Formulation: A crystalline solid